4723-9-02 Requirements for a course of study in advanced pharmacology.

 

 

 

4723-9-02                    Requirements for a course of study in advanced pharmacology.

 

 

 

(A)    Except as provided in paragraph (B) of this rule, to be acceptable to the board, a course of study shall meet the following requirements:

 

(1)   Be a minimum of forty-five contact hours in length and include content which ensures sufficient preparation for the safe and effective prescribing of drugs and therapeutic devices;

 

(2)   Include content which is specific to the participant's nursing specialty and which includes all of the following:

 

(a)      A  minimum  of  thirty-six  hours  of  training,  obtained  from  a  single provider, in:

 

(i)   Pharmacokinetic principles and clinical application; and

 

(ii)      Principles  of  the  use  of  drugs  and  therapeutic  devices  in  the prevention of illness and maintenance of health;

 

(b)     Information on the state and federal laws and rules that apply to the authority to prescribe; and

 

(c)    Information on fiscal and ethical implications of prescribing drugs and therapeutic devices;

 

(3)   Include a process for interaction of the participants with instructional personnel;

 

(4)   Include a process for evaluation the participant's learning of the content required by this rule which includes:

 

(a)   Successful completion of case studies or written assignments;

 

(b)   Successful completion of a comprehensive written examination; or

 

(c)   A mechanism to assure the security of the evaluation process; and

 

(5)   Be faculty-directed and obtained either from:

 

(a)  An accredited educational institution acceptable to the board; or

 

 

 

 

(b)      A continuing education program in pharmacology which has been submitted individually for approval to an Ohio board of nursing approver and approved or accepted in accordance with Chapter 4723-14 of the Administrative Code.

(c)     Until July 1, 2002, any equivalent pharmacology program which is specifically approved by the board.

(B)   On or before three years after the effective date of this ruleOctober 1, 2004, a course of study acceptable to the board shall consist of a minimum of thirty-six contact hours of training in advanced pharmacology, of which a minimum of thirty hours shall be offered by a single provider and include the content specified in paragraph (A)(2)(a) of this rule and six hours of content specified in paragraphs (A)(2)(b) and (A)(2)(c) of this rule provided by no more than two additional providers.

Effective:                                02/01/2003 R.C. 119.032 review dates:                           10/11/2005

CERTIFIED ELECTRONICALLY

Certification

01/21/2003

Date

Promulgated Under:   119.03

Statutory Authority:   4723.50

Rule Amplifies:           4723.482

Prior Effective Dates: 10/1/01, 2/1/02